Llamas-Esperon G, Berrios-Barcenas E, Cossio-Aranda J, Guerra-Lopez A, Magana-Serrano J, Iturralde-Torres P
Arch Cardiol Mex. 2025; 94(Supl 4):1-75.
PMID: 39928711
PMC: 11824882.
DOI: 10.24875/ACM.M25000098.
Delbarre M, Chadha G, Annabi M, Nouri R, Zaroui A, Blanc-Durand P
J Intern Med. 2024; 297(2):186-200.
PMID: 39610264
PMC: 11771575.
DOI: 10.1111/joim.20042.
Tikait P, Sharma R, Kewlani A, Kutum C, Choudhary R
Cureus. 2024; 16(8):e67115.
PMID: 39290945
PMC: 11406825.
DOI: 10.7759/cureus.67115.
Shore S, Ervin C, Kosa K, Fehnel S, Salberg L, Butzner M
BMJ Open. 2024; 14(9):e081323.
PMID: 39289016
PMC: 11409399.
DOI: 10.1136/bmjopen-2023-081323.
Yetiskul E, Hussain M, Khan D, Khan S, Spagnola J
Cureus. 2024; 16(4):e57437.
PMID: 38699093
PMC: 11063810.
DOI: 10.7759/cureus.57437.
Effect of metoprolol in hypertrophic obstructive cardiomyopathy patients after alcohol septal ablation.
Hnatova H, Fulinova K, rihakova B, Bonaventura J, Veselka J
Int J Cardiol Heart Vasc. 2023; 49:101317.
PMID: 38126007
PMC: 10731216.
DOI: 10.1016/j.ijcha.2023.101317.
Differentiating Cardiac Troponin Levels During Cardiac Myosin Inhibition or Cardiac Myosin Activation Treatments: Drug Effect or the Canary in the Coal Mine?.
Lee M, Masri A
Curr Heart Fail Rep. 2023; 20(6):504-518.
PMID: 37875744
PMC: 10746589.
DOI: 10.1007/s11897-023-00620-2.
Hypertrophic Cardiomyopathy: A Cardiovascular Challenge Becoming a Contemporary Treatable Disease.
Sakellaropoulos S, Steinberg B
Cardiol Res. 2023; 14(4):243-249.
PMID: 37559708
PMC: 10409543.
DOI: 10.14740/cr1514.
Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis.
Deraz S, Esmat O, El-Hmid R, Amin S
Egypt Heart J. 2023; 75(1):54.
PMID: 37389694
PMC: 10313626.
DOI: 10.1186/s43044-023-00382-1.
Role of Surface Electrocardiography in Differentiation between Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy.
Nourani M, Mirzaie M, Sadr-Ameli M, Fazelifar A, Haghjoo M
J Tehran Heart Cent. 2023; 18(1):46-51.
PMID: 37252213
PMC: 10225031.
DOI: 10.18502/jthc.v18i1.12581.
Hypertension in the Setting of Hypertrophic Obstructive Cardiomyopathy and Cocaine Use.
Miller D, Hosna A, Salam S, Stern R, Bakshi S
Cureus. 2022; 14(10):e30090.
PMID: 36381699
PMC: 9641723.
DOI: 10.7759/cureus.30090.
Mitral Valve Systolic Anterior Motion in Robotic Thoracic Surgery as the Cause of Unexplained Hemodynamic Shock: From a Case Report to Recommendations.
Monaco F, DAmico F, Barucco G, Licheri M, Novellis P, Ciriaco P
J Clin Med. 2022; 11(20).
PMID: 36294365
PMC: 9604796.
DOI: 10.3390/jcm11206044.
Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy.
Palumbo P, Masedu F, De Cataldo C, Cannizzaro E, Bruno F, Pradella S
Radiol Med. 2021; 126(12):1532-1543.
PMID: 34894317
DOI: 10.1007/s11547-021-01432-x.
The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy.
Alis D, Guler A, Asmakutlu O, Topel C, Sahin A
Indian J Radiol Imaging. 2021; 31(2):284-290.
PMID: 34556909
PMC: 8448239.
DOI: 10.1055/s-0041-1734333.
Myosin Modulators: The New Era of Medical Therapy for Systolic Heart Failure and Hypertrophic Cardiomyopathy.
Lekaditi D, Sakellaropoulos S
Cardiol Res. 2021; 12(3):146-148.
PMID: 34046107
PMC: 8139755.
DOI: 10.14740/cr1243.
Risk stratification for sudden cardiac death after septal myectomy.
Rothman R, Safiia M, Lowry P, Mela T, Abbara S, OCallaghan C
J Cardiol Cases. 2018; 3(2):e65-e67.
PMID: 30532839
PMC: 6265092.
DOI: 10.1016/j.jccase.2010.12.002.
Tunable Elastomers with an Antithrombotic Component for Cardiovascular Applications.
Stahl A, Yang Y
Adv Healthc Mater. 2018; 7(16):e1800222.
PMID: 29855176
PMC: 6317886.
DOI: 10.1002/adhm.201800222.
Takotsubo cardiomyopathy with Basal Hypertrophy and outflow obstruction in a patient with bowel ischemia.
Abuarqoub A, Garis R, Shaaban H, Khaddash I, Shamoon F
Int J Crit Illn Inj Sci. 2018; 8(1):44-47.
PMID: 29619340
PMC: 5869801.
DOI: 10.4103/IJCIIS.IJCIIS_47_17.
Transmitral myectomy and how to deal with systolic anterior motion (SAM) in hypertrophic obstructive cardiomyopathy.
Meier S, Noack T, Mohr F, Seeburger J, Passage J
Ann Cardiothorac Surg. 2017; 6(4):416-418.
PMID: 28944184
PMC: 5602199.
DOI: 10.21037/acs.2017.06.01.
Comparison of echocardiography with tissue Doppler imaging and magnetic resonance imaging with delayed enhancement in the assessment of children with hypertrophic cardiomyopathy.
Ziolkowska L, Petryka J, Boruc A, Kawalec W
Arch Med Sci. 2017; 13(2):328-336.
PMID: 28261285
PMC: 5332448.
DOI: 10.5114/aoms.2016.60404.
